Self-reinforcing market forces are creating demand for Michael Saylor’s ‘lottery ticket’ convertible bonds
Despite massive fundraising plans, the stock is up 450% this year, valuing the company at about $90bn
At-the-market equity offering; in-your-face bitcoin evangelism
Bold action signals aerospace giant is trying to take risk of financial distress off the table
It’s another lean year for equity new issues, but might there be signs of life?
Investment banks’ favourite employee evaluation tool is easily gamed and frequently undermined
Deal is a textbook example of how not to create price tension in a capital markets offering
Bespoke banking can never be nine-to-five
Ack-man of La Mancha
No Go! No Go! Ackman
Dual-class struggles
Investors can't be sold the ‘Permira discount’
After the election British policymakers urgently need to jump-start the City’s capital-raising engine
There’s no fight for your rights
Attention Zeekr
Top-tier asset, cheap pricing, savvy tactics. And balloons
We’re Miffed Too
Recent flotations of Galderma and Douglas underscore that fund managers are still being selective
Tricky exits
A conservative directed-share program on its IPO risks leaving the Redditor army feeling left out
‘Inconsequential, parochial and mildly protectionist’
Tactical trial balloon or a real possibility?
More Goldman drama
Loss of chip company listing to New York shows why it’s time to revive London as an IPO venue
Placebo Advisers
